Sii Investments Inc. WI Has $408,000 Position in Danaher Corporation (DHR)

Sii Investments Inc. WI cut its holdings in Danaher Corporation (NYSE:DHR) by 8.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,829 shares of the conglomerate’s stock after selling 454 shares during the quarter. Sii Investments Inc. WI’s holdings in Danaher Corporation were worth $408,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Norway Savings Bank lifted its position in Danaher Corporation by 0.4% in the 2nd quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock valued at $189,000 after acquiring an additional 10 shares in the last quarter. First Financial Corp IN lifted its position in Danaher Corporation by 0.8% in the 2nd quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock valued at $230,000 after acquiring an additional 21 shares in the last quarter. Brighton Jones LLC lifted its position in Danaher Corporation by 0.4% in the 2nd quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock valued at $435,000 after acquiring an additional 21 shares in the last quarter. Guardian Life Insurance Co. of America lifted its position in Danaher Corporation by 1.0% in the 1st quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock valued at $202,000 after acquiring an additional 24 shares in the last quarter. Finally, Buckingham Asset Management LLC lifted its position in Danaher Corporation by 0.4% in the 2nd quarter. Buckingham Asset Management LLC now owns 5,778 shares of the conglomerate’s stock valued at $488,000 after acquiring an additional 24 shares in the last quarter. 75.49% of the stock is currently owned by institutional investors and hedge funds.

Danaher Corporation (DHR) opened at 91.81 on Tuesday. The company has a 50-day moving average price of $87.67 and a 200-day moving average price of $84.50. Danaher Corporation has a one year low of $76.27 and a one year high of $92.26. The company has a market capitalization of $63.78 billion, a PE ratio of 29.30 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.05. The business had revenue of $4.53 billion during the quarter, compared to the consensus estimate of $4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.87 earnings per share. Analysts expect that Danaher Corporation will post $3.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a $0.14 dividend. The ex-dividend date was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.61%. Danaher Corporation’s dividend payout ratio (DPR) is currently 16.52%.

TRADEMARK VIOLATION NOTICE: This news story was posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.com-unik.info/2017/10/31/sii-investments-inc-wi-has-408000-position-in-danaher-corporation-dhr.html.

DHR has been the topic of several analyst reports. Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and set a $83.00 price target on shares of Danaher Corporation in a report on Tuesday, September 26th. Credit Suisse Group increased their price target on Danaher Corporation from $93.00 to $96.00 and gave the company an “outperform” rating in a report on Friday, October 20th. BidaskClub raised Danaher Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. Finally, J P Morgan Chase & Co reissued an “overweight” rating and set a $95.00 price target on shares of Danaher Corporation in a report on Friday, September 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Danaher Corporation has a consensus rating of “Buy” and an average price target of $93.31.

In other Danaher Corporation news, CAO Robert S. Lutz sold 11,189 shares of the company’s stock in a transaction dated Monday, October 23rd. The shares were sold at an average price of $91.66, for a total value of $1,025,583.74. Following the completion of the transaction, the chief accounting officer now owns 18,314 shares in the company, valued at $1,678,661.24. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Daniel L. Comas sold 88,184 shares of the company’s stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $91.02, for a total transaction of $8,026,507.68. Following the completion of the transaction, the chief financial officer now owns 227,816 shares of the company’s stock, valued at approximately $20,735,812.32. The disclosure for this sale can be found here. In the last quarter, insiders sold 153,639 shares of company stock valued at $13,632,773. Insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit